Spots Global Cancer Trial Database for locally advanced head and neck cancer
Every month we try and update this database with for locally advanced head and neck cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer | NCT03317730 | Locally Advance... | Xtampza ER | 19 Years - | University of Alabama at Birmingham | |
| DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC | NCT02976051 | Locally Advance... Radiotherapy Hypoxic Radiore... | HART-CN | 18 Years - | Danish Head and Neck Cancer Group | |
| Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio) | NCT02059668 | Head and Neck C... | Biomarker analy... | 18 Years - | Technische Universität Dresden | |
| Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer | NCT03532737 | Locally Advance... | Pembrolizumab | 16 Years - | Kuwait Cancer Control Center | |
| Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer | NCT03317730 | Locally Advance... | Xtampza ER | 19 Years - | University of Alabama at Birmingham | |
| Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer | NCT03317730 | Locally Advance... | Xtampza ER | 19 Years - | University of Alabama at Birmingham | |
| Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer | NCT01588431 | Carcinoma, Squa... | Docetaxel, Cisp... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
| A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer. | NCT01969877 | Locally Advance... | cetuximab cisplatin | 18 Years - | Lund University Hospital | |
| Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
| A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer | NCT03699969 | Locally Advance... | Hypofractionate... | 18 Years - 70 Years | Cairo University | |
| DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC | NCT02976051 | Locally Advance... Radiotherapy Hypoxic Radiore... | HART-CN | 18 Years - | Danish Head and Neck Cancer Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
